EDA and fatty liver disease: EDA is a hepatokine belonging to the superfamily of the TNF superfamily that has been reported to alter systemic insulin sensitivity in obesity and promote the activation of proinflammatory pathways, but also could aggravate hepatic steatosis by striking a balance between lipid deposition and elimination [59,60].